Prelude Therapeutics Incorporated (PRLD)
PRLD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.56
-4.81% on the day
Market cap
$284.1M
Micro cap
Revenue · 2025
$12.1M
+73.4% on 2024
Net income · 2025
-$99.5M
-819.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | PRLD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001678660 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $12.1M |
| Net income | -$99.5M |
| Operating income | -$104.6M |
| Net margin | -819.6% |
| Operating margin | -861.3% |
| Revenue growth | +73.4% |
| Cash | $35.3M |
| Total assets | $141.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 23.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-21 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-10 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 389 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| FULC | Fulcrum Therapeutics Inc. | $3.68 | -1.87% | $281.1M |
| BNTC | Benitec Biopharma Inc. | $8.63 | -4.85% | $301.0M |
| CYPH | Cypherpunk Technologies Inc. | $2.84 | -2.07% | $306.1M |
| VNDA | Vanda Pharmaceuticals Inc. | $4.30 | -5.29% | $260.0M |
| CATX | Perspective Therapeutics Inc. | $2.27 | -9.92% | $259.1M |
| ABEO | Abeona Therapeutics Inc. | $4.52 | -7.75% | $258.5M |
| BIOA | BioAge Labs Inc. | $5.57 | -6.23% | $255.6M |
| TTRX | Turn Therapeutics Inc. | $10.60 | -4.59% | $315.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier